Authors : Cho J; Laboratory for Financial Engineering, MIT, Cambridge, MA, United States of America.; Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA, United States of America.

Subjects: Biological Products* ; Drug Industry*; Biotechnology

Source: PloS one [PLoS One] 2024 Jan 26; Vol. 19 (1), pp. e0296927. Date of Electronic Publication: 2024 Jan 26 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list

Academic Journal

Assessing the critical success factors for implementing industry 4.0 in the pharmaceutical industry: Implications for supply chain sustainability in emerging economies.

Authors : Debnath B; Department of Industrial and Production Engineering, Bangladesh University of Engineering and Technology, Dhaka, Bangladesh.; Shakur MS

Subjects: Commerce* ; Drug Industry*; Bayes Theorem

Source: PloS one [PLoS One] 2023 Jun 15; Vol. 18 (6), pp. e0287149. Date of Electronic Publication: 2023 Jun 15 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list

Academic Journal

Changes in Japanese physicians' relationships with the pharmaceutical industry between 2008 and 2021: A national survey.

Authors : Saito S; Department of General Medicine, National Hospital Organization Kasumigaura Medical Center, Tsuchiura, Ibaraki, Japan.; Mukohara K

Subjects: Drug Industry* ; Interprofessional Relations* ; Physicians*

Source: PloS one [PLoS One] 2023 Jun 01; Vol. 18 (6), pp. e0286339. Date of Electronic Publication: 2023 Jun 01 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list

Academic Journal

Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019.

Authors : Murayama A; Tohoku University School of Medicine, Sendai, Miyagi, Japan. .; Kamamoto S

Subjects: Conflict of Interest* ; Dermatologists* ; Drug Industry*

Source: Scientific reports [Sci Rep] 2023 May 08; Vol. 13 (1), pp. 7425. Date of Electronic Publication: 2023 May 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

The impact of corporate governance on the total factor productivity of pharmaceutical enterprises: a study based on the fsQCA method.

Authors : Gao L; First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.; Dong F

Subjects: Medicine* ; Pharmacy*; Humans

Source: Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3285. Date of Electronic Publication: 2024 Feb 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

The Political Economy of Market Power in Pharmaceuticals.

Authors : Kapczynski A; Yale University.

Subjects: Commerce* ; Drug Industry*; Humans

Source: Journal of health politics, policy and law [J Health Polit Policy Law] 2023 Apr 01; Vol. 48 (2), pp. 215-239.Publisher: Duke Univ. Press Country of Publication: United States NLM ID: 7609331 Publication Model: Print Cited Medium: Internet ISSN: 1527-1927

Record details

Read Online Read More Add to Saved list

Academic Journal

Current career situations of Chinese pharmacovigilance professionals working for pharmaceutical companies: an exploratory survey.

Authors : Tang Y; The Department of Clinical Pharmacy, School of Pharmacy, Chongqing Medical University, Chongqing, China.; Liu Y

Subjects: Pharmacovigilance* ; Drug Industry*; Humans

Source: BMC health services research [BMC Health Serv Res] 2023 Feb 14; Vol. 23 (1), pp. 152. Date of Electronic Publication: 2023 Feb 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

Record details

Read Online Read More Add to Saved list

Academic Journal

Investigation of mixing homogeneity of binary particle systems in high-shear wet granulator by DEM.

Authors : Fan R; Chongqing Key Laboratory of Industrial Fermentation Microorganisms, College of Chemistry and Chemical Engineering, Chongqing University of Science and Technology, Chongqing, China.; Zhao M

Subjects: Technology, Pharmaceutical*/Technology, Pharmaceutical*/Technology, Pharmaceutical*/methods ; Drug Industry*; Particle Size

Source: Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2023 Feb; Vol. 49 (2), pp. 179-188. Date of Electronic Publisher: Informa Healthcare Country of Publication: England NLM ID: 7802620 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

[The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].

Authors : Henn DK; AstraZeneca GmbH, Hamburg, Deutschland.; Ruppert T

Subjects: Drug Industry* ; Clinical Trials as Topic*; Ethics Committees

Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2023 Jan; Vol. 66 (1), pp. 28-37. Date of Electronic Publisher: Springer Country of Publication: Germany NLM ID: 101181368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-1588

Record details

Read Online Read More Add to Saved list

Academic Journal

[More transparency in clinical research: How are the new transparency regulations assessed from the perspective of the pharmaceutical industry?]

Authors : Wachenhausen H; Wachenhausen Rechtsanwälte Partnerschaft Mbb, Fünfhausen 1, 23552, Lübeck, Deutschland.; Bundesverband der Pharmazeutischen Industrie e. V. (BPI), Friedrichstraße 148, 10117, Berlin, Deutschland.

Subjects: Drug Industry* ; Clinical Trials as Topic*; Humans

Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2023 Jan; Vol. 66 (1), pp. 60-67. Date of Electronic Publisher: Springer Country of Publication: Germany NLM ID: 101181368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-1588

Record details

Read Online Read More Add to Saved list